British Scientists Use Mould to Create Biological Robot

Slime mould usually gets a bad rap but this microscopic fungus is a star player in the scientific world. British researchers have announced they will use slime mould to design the first ever biological robot: a development that will impact the field of computational robotics.

The scientists from the University of the West of England (UWE) Bristol presented 'plasmobot', an amorphous, non-silicon biological robot. The key ingredient in their design was plasmodium, which is the vegetative stage of the slime mould Physarum polycephalum that is commonly found in forests and gardens in the UK.

Project leader Andy Adamatzky of the Department of Computer Science at UWE Bristol said the team's previous work proved how mould is capable of having computational skills. "Most people's idea of a computer is a piece of hardware with software designed to carry out specific tasks. This mould, or plasmodium, is a naturally occurring substance with its own embedded intelligence," he explained.

"It propagates and searches for sources of nutrients and when it finds such sources it branches out in a series of veins of protoplasm," Professor Adamatzky added. "The plasmodium is capable of solving complex computational tasks, such as the shortest path between points and other logical calculations."

The team succeeded in making the mould transport objects in previous experiments, he said. "By feeding it oat flakes, it grows tubes which oscillate and make it move in a certain direction carrying objects with it," Professor Adamatzy said. "We can also use light or chemical stimuli to make it grow in a certain direction."

The plasmobot could sense and span objects, and transport small objects along pre-programmed directions, according to the UWE researcher. "The robots will have parallel inputs and outputs, a network of sensors and the number of crunching power of super computers," he said. "The plasmobot will be controlled by spatial gradients of light, electro-magnetic fields and the characteristics of the substrate on which it is placed."

Professor Adamatzy pointed out that the plasmobot will be a "fully controllable and programmable amorphous intelligent robot with an embedded massively parallel computer."

This latest development will clear the path for the team to conduct further experiments on how mould can be controlled and used for its computational abilities.

"We are at the very early stages of our understanding of how the potential of the plasmodium can be applied, but in years to come we may be able to use the ability of the mould for example to deliver a small quantity of a chemical substance to a target, using light to help to propel it, or the movement could be used to help assemble micro-components of machines," Professor Adamatzky remarked.

The next development would be to harness the power of plasmodia within the human body. The delivery of drugs to certain parts of the body is an example.

"It might also be possible for thousands of tiny computers made of plasmodia to live on our skin and carry out routine tasks freeing up our brain for other things," Professor Adamatzy surmised. "Many scientists see this as a potential development of amorphous computing, but it purely theoretical at the moment."

For further information, please visit:
University of the West of England, http://www.uwe.ac.uk

Copyright ©European Communities, 2009
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...